AIA
ABBV icon

AIMZ Investment Advisors’s AbbVie ABBV Stock Holding History

AIMZ Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
15,376
-122
-0.8% -$26.2K 1.06% 28
2026
Q1 		$3.37M Sell
15,498
-63
-0.4% -$14K 1.04% 31
2025
Q4 		$3.56M Sell
15,561
-98
-0.6% -$22.3K 1.02% 31
2025
Q3 		$3.63M Sell
15,659
-47
-0.3% -$9.57K 1.14% 29
2025
Q2 		$2.92M Buy
15,706
+4
+0% +$743 0.98% 34
2025
Q1 		$3.29M Sell
15,702
-46
-0.3% -$8.94K 1.15% 30
2024
Q4 		$2.8M Sell
15,748
-97
-0.6% -$17.8K 0.97% 30
2024
Q3 		$3.13M Sell
15,845
-222
-1% -$41.4K 1.07% 31
2024
Q2 		$2.76M Buy
16,067
+3
+0% +$497 0.99% 32
2024
Q1 		$2.93M Sell
16,064
-296
-2% -$51K 1.09% 31
2023
Q4 		$2.54M Sell
16,360
-307
-2% -$44.8K 1.03% 33
2023
Q3 		$2.48M Sell
16,667
-96
-0.6% -$14.1K 1.1% 32
2023
Q2 		$2.26M Buy
16,763
+3
+0% +$440 0.97% 37
2023
Q1 		$2.67M Sell
16,760
-321
-2% -$49.1K 1.2% 28
2022
Q4 		$2.76M Sell
17,081
-297
-2% -$45.5K 1.3% 28
2022
Q3 		$2.33M Sell
17,378
-122
-0.7% -$17.5K 1.18% 31
2022
Q2 		$2.68M Buy
17,500
+3
+0% +$458 1.29% 30
2022
Q1 		$2.84M Sell
17,497
-797
-4% -$116K 1.17% 30
2021
Q4 		$2.48M Buy
18,294
+504
+3% +$59.5K 0.96% 39
2021
Q3 		$1.92M Buy
17,790
+4
+0% +$457 0.87% 41
2021
Q2 		$2M Buy
17,786
+3
+0% +$338 0.9% 40
2021
Q1 		$1.92M Sell
17,783
-135
-0.8% -$14.4K 0.94% 41
2020
Q4 		$1.92M Buy
17,918
+43
+0.2% +$4.13K 1.01% 38
2020
Q3 		$1.57M Buy
17,875
+4
+0% +$377 0.94% 40
2020
Q2 		$1.75M Sell
17,871
-24
-0.1% -$2.11K 1.14% 34
2020
Q1 		$1.36M Sell
17,895
-147
-0.8% -$12.5K 1.06% 36
2019
Q4 		$1.6M Sell
18,042
-96
-0.5% -$7.97K 1.03% 36
2019
Q3 		$1.37M Sell
18,138
-8
-0% -$548 0.95% 40
2019
Q2 		$1.32M Buy
18,146
+4
+0% +$314 0.91% 42
2019
Q1 		$1.46M Buy
18,142
+4
+0% +$327 1% 38
2018
Q4 		$1.67M Sell
18,138
-147
-0.8% -$12.9K 1.29% 33
2018
Q3 		$1.73M Sell
18,285
-98
-0.5% -$9.29K 1.11% 35
2018
Q2 		$1.7M Sell
18,383
-97
-0.5% -$9.47K 1.21% 30
2018
Q1 		$1.75M Sell
18,480
-548
-3% -$60.2K 1.27% 30
2017
Q4 		$1.84M Sell
19,028
-199
-1% -$18.8K 1.38% 26
2017
Q3 		$1.71M Buy
19,227
+3
+0% +$228 1.4% 23
2017
Q2 		$1.39M Sell
19,224
-405
-2% -$27.2K 1.17% 32
2017
Q1 		$1.28M Sell
19,629
-97
-0.5% -$6.1K 1.08% 38
2016
Q4 		$1.24M Buy
19,726
+2
+0% +$122 1.1% 35
2016
Q3 		$1.24M Sell
19,724
-32
-0.2% -$2.07K 1.11% 33
2016
Q2 		$1.22M Sell
19,756
-20,593
-51% -$1.25M 1.12% 37
2016
Q1 		$2.33M Buy
40,349
+20,048
+99% +$1.12M 1.03% 35
2015
Q4 		$1.2M Buy
20,301
+2
+0% +$115 1.1% 38
2015
Q3 		$1.1M Sell
20,299
-98
-0.5% -$6.38K 1.01% 38
2015
Q2 		$1.37M Buy
20,397
+2
+0% +$131 1.19% 31
2015
Q1 		$1.19M Buy
20,395
+237
+1% +$14.3K 1.02% 38
2014
Q4 		$1.32M Buy
+20,158
New +$1.27M 1.18% 31

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AIMZ Investment Advisors's ABBV Position: Q2 2026 in Review

AIMZ Investment Advisors reduced its AbbVie (ABBV) stake by 0.79% in Q2 2026, selling an estimated $26.2K and leaving 15,376 shares worth $3.87M. The position accounts for 1.06% of the portfolio, ranked #28.

AIMZ Investment Advisors first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AIMZ Investment Advisors held 15,376 shares of AbbVie worth $3.87M as of Q2 2026.
  • AIMZ Investment Advisors sold 122 AbbVie shares in Q2 2026, an estimated $26.2K.
  • AbbVie made up 1.06% of AIMZ Investment Advisors's portfolio in Q2 2026, its #28 holding.
  • AIMZ Investment Advisors first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.